18.60 USD
↗ 0.00 (0.00%)PRE MARKET (AS OF 07:41 PM EDT)
Zenas BioPharma, Inc. Common Stock
ZBIONASDAQ • USD
Market: OPEN
Open?$18.04
High?$18.96
Low?$18.27
Prev. Close?$18.59
Volume?282.8K
Avg. Volume?863.2K
VWAP?$18.54
Rel. Volume?0.33x
Bid / Ask
Bid?$15.55 × 100
Ask?$21.78 × 100
Spread?$6.23
Midpoint?$18.67
Valuation & Ratios
Market Cap?1.2B
Shares Out?57.4M
Float?14.3M
Float %?26.6%
P/E Ratio?N/A
P/B Ratio?4.79
EPS?-$6.06
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.61Strong
Quick Ratio?5.61Strong
Cash Ratio?1.77Strong
Debt/Equity?0.32Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?4.79FAIR▾
P/S?115.95HIGH▾
P/FCF?N/A▾
EV/EBITDA?-2.9CHEAP▾
EV/Sales?112.75HIGH▾
Returns & Efficiency
ROE?-156.0%WEAK▾
ROA?-98.5%WEAK▾
Cash Flow & Enterprise
FCF?$-172351000
Enterprise Value?$1.1B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
Employees
167
Market Cap
1.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-09-13
Address
852 WINTER STREET, SUITE 250
WALTHAM, MA 02451
Phone: 857-271-2954
WALTHAM, MA 02451
Phone: 857-271-2954